Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisAntigens, CD34Hematologic NeoplasmsCombined Modality TherapyBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseHematopoietic Stem CellsBusulfanStem CellsMyeloablative AgonistsTreatment OutcomeGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCord Blood Stem Cell TransplantationCytophagocytosisCarmustineIfosfamideSalvage TherapyHematopoiesisVincristineAmyloidosisCytarabineHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraTissue DonorsRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationInfectionSurvival AnalysisTime FactorsHistocompatibilityDoxorubicinPOEMS SyndromeLymphoma, T-CellPlatelet CountHistocompatibility TestingBlood Cell CountImmunosuppressive AgentsCarboplatinPrednisoneVidarabineLeukemia, Myeloid, AcuteTransplantation, IsogeneicBlood CellsLeukemiaDexamethasoneRecombinant ProteinsBone Marrow PurgingFollow-Up StudiesLymphomaAntineoplastic AgentsCytomegalovirus InfectionsGraft vs Leukemia EffectProspective StudiesFatal OutcomeFeasibility StudiesEmbryonic Stem CellsImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticAdult Stem CellsMesenchymal Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionBlood Transfusion, AutologousHematologic DiseasesBlood DonorsBone MarrowHistiocytosis, Non-Langerhans-CellCell SeparationT-LymphocytesOpportunistic InfectionsLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver TransplantationHLA AntigensLeukocytes, MononuclearCyclosporineFlow Cytometry